Global Pharmaceuticals & Biotech Breakout Stocks

BioNTech

Market Cap: US$28.3b

Engages in the development and commercialization of immunotherapies in Germany.

Genscript Biotech

Market Cap: HK$76.6b

An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.

Twist Bioscience

Market Cap: US$8.8b

Manufactures and sells synthetic DNA-based products.

Hanmi Pharm

Market Cap: ₩6.4t

A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.

Iovance Biotherapeutics

Market Cap: US$3.7b

A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States and internationally.

Pell Bio-Med Technology

Market Cap: NT$88.8b

A biomedical company, engages in the research, development, manufacturing, and sales of chimeric antigen recombinant T cell (CAR-T), and other related services and products.

Maravai LifeSciences Holdings

Market Cap: US$2.2b

A life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America.

Personalis

Market Cap: US$1.8b

Develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally.

Inhibrx Biosciences

Market Cap: US$1.5b

A clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions.

Jenkem Technology

Market Cap: CN¥8.1b

Engages in the research, development, production, and sale of medical and pharmaceutical polyethylene glycol (PEG), and its derivatives in China and internationally.

Immix Biopharma

Market Cap: US$973.7m

A clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia.

Hunan Hansen Pharmaceutical

Market Cap: CN¥6.2b

Engages in the production and sale of traditional Chinese preparations in China and internationally.

Novoprotein Scientific

Market Cap: CN¥5.8b

Researches, develops, produces, and sells raw materials and technical solutions for bio-pharmaceutical enterprises and research institutions in Asia, Europe, the United States, and Oceania.

Nuvectis Pharma

Market Cap: US$777.7m

A clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology.

Shanghai Shenqi Pharmaceutical Investment Management

Market Cap: CN¥5.1b

Operates as a pharmaceutical manufacturing holding investment company in China.

Xinjiang Tianshan Animal Husbandry Bio-engineering

Market Cap: CN¥4.0b

Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd.

Entera Bio

Market Cap: US$592.1m

A clinical stage company, engages in the development of oral peptides and protein replacement therapies in Israel and internationally.

Prime Medicine

Market Cap: US$578.2m

A biotechnology company, engages in delivering genetic medicines to address the spectrum of diseases by deploying gene editing technology in the United States.

Gongwin Biopharm Holdings

Market Cap: NT$14.0b

A clinical-stage biopharmaceutical company, develops anticancer drugs in Hong Kong, China, and Singapore.

Jilin Province Xidian Pharmaceutical Sci-Tech DevelopmentLtd

Market Cap: CN¥2.9b

Engages in the research, development, production, and sales of chemical raw materials and pharmaceutical preparations in China.

Pacific Biosciences of California

Market Cap: US$397.9m

Designs, develops, and manufactures sequencing solutions to resolve genetically complex problems.

Circio Holding

Market Cap: NOK 2.8b

A biotechnology company, develops novel circular RNA expression technology for gene and cell therapy.

Compugen

Market Cap: US$245.3m

A clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe.

Cypherpunk Technologies

Market Cap: US$181.0m

A privacy technology company, implements a digital asset strategy anchored by Zcash in the United States.

Nykode Therapeutics

Market Cap: NOK 1.5b

A clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies for the treatment of cancer and autoimmune diseases.

Medivir

Market Cap: SEK 1.3b

A pharmaceutical company, focuses on the development and commercialization of medical treatments in areas of high unmet medical need in Sweden, the Nordic region, the rest of Europe, and internationally.

Rafael Holdings

Market Cap: US$113.9m

Primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and medical devices in the United States and Israel.

WITHUS PHARMACEUTICALLTD

Market Cap: ₩118.7b

Engages in the production and sale of pharmaceutical products in South Korea.

Sareum Holdings

Market Cap: UK£51.3m

A clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases.

RenovoRx

Market Cap: US$56.4m

A clinical-stage biopharmaceutical company, engages in developing targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment.

iAnthus Capital Holdings

Market Cap: CA$69.7m

Owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States.

1CM

Market Cap: CA$37.1m

A multi-jurisdictional cannabis company, retails cannabis, alcohol, tobacco, nicotine, and consumer packaged goods in Canada.

Marker Therapeutics

Market Cap: US$25.0m

A clinical-stage immuno-oncology company, develops and commercializes T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications in the United States.

Pharmala Biotech Holdings

Market Cap: CA$28.4m

A biotechnology company, engages in the development, manufacture, and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community.

Intravenous Infusions

Market Cap: GH₵192.1m

A pharmaceutical company, engages in the manufacturing and marketing of intravenous infusions and small volume injectables for therapeutic purposes in Ghana and the West African sub-region.

BioVie

Market Cap: US$16.1m

A clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States.